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Porcine reproductive and respiratory syndrome virus (PRRSV) is an RNA virus replicating in the cytoplasm, but the nucleocapsid (N) protein
is specifically localized to the nucleus and nucleolus in virus-infected cells. A Fpat7_ motif of 41-PGKK(N/S)KK has previously been identified in
the N protein as the functional nuclear localization signal (NLS); however, the biological consequences of N protein nuclear localization are
unknown. In the present study, the role of N protein nuclear localization during infection was investigated in pigs using an NLS-null mutant virus.
When two lysines at 43 and 44 at the NLS locus were substituted to glycines, the modified NLS with 41-PGGGNKK restricted the N protein to the
cytoplasm. This NLS-null mutation was introduced into a full-length infectious cDNA clone of PRRSV. Upon transfection of cells, the NLS-null
full-length clone induced cytopathic effects and produced infectious progeny. The NLS-null virus grew to a titer 100-fold lower than that of wild-
type virus. To examine the response to NLS-null PRRSV in the natural host, three groups of pigs, consisting of seven animals per group, were
intranasally inoculated with wild-type, placebo, or NLS-null virus, and the animals were maintained for 4 weeks. The NLS-null-infected pigs had
a significantly shorter mean duration of viremia than wild-type-infected pigs but developed significantly higher titers of neutralizing antibodies.
Mutations occurred at the NLS locus in one pig during viremia, and four types of mutations were identified: 41-PGRGNKK, 41-PGGRNKK, and
41-PGRRNKK, and 41-PGKKSKK. Both wild-type and NLS-null viruses persisted in the tonsils for at least 4 weeks, and the NLS-null virus
persisting in the tonsils was found to be mutated to either 41-PGRGNKK or 41-PGGRNKK in all pigs. No other mutation was found in the N
gene. All types of reversions which occurred during viremia and persistence were able to translocate the mutated N proteins to the nucleus,
indicating a strong selection pressure for reversion at the NLS locus of the N protein in vivo. Reversions from NLS-null to functional NLS in the
tonsils suggest a possible correlation of viral persistence with N protein nuclear localization. These results show that N protein nuclear localization
is non-essential for PRRSV multiplication but may play an important role in viral attenuation and in pathogenesis in vivo.
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Porcine reproductive and respiratory syndrome (PRRS) is an
emerged infectious disease of swine and causes significant
economic losses to the pig industry worldwide (Albina, 1997).
The disease was first recognized in North America in 1987
(Keffaber, 1989) and subsequently in Europe in 1990. Soon0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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for the disease in the USA and in The Netherlands (Benfield et
al., 1992; Wensvoort et al., 1991). PRRSV has quickly become
endemic in nearly all pig-producing countries and is now
considered one of the most economically important pathogens
of swine worldwide. PRRSV grows preferentially in porcine
alveolar macrophages and establishes a persistent infection of
up to 5 months in infected pigs (Allende et al., 2000; Wills et
al., 1997). Although North American and European isolates of
PRRSV cause similar clinical signs and share the same
morphology and genome organization, they exhibit significant6) 238 – 250
www.e
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sequence homology at the genome level. Consequently,
PRRSV is divided into two genotypes, the European genotype
and North American genotype (Meng et al., 1995; Nelsen et al.,
1999; Nelson et al., 1993; Wootton et al., 2000).
PRRSV is a small, enveloped virus possessing a single-
stranded positive-sense RNA genome of approximately 15 kb
in size (Meulenberg et al., 1993; Snijder and Meulenberg,
1998; Wootton et al., 2000). The genome is 5V-capped and 3V-
polyadenylated (Sagripanti et al., 1986; Wootton et al., 2000)
and belongs to the family Arteriviridae along with equine
arteritis virus (EAV), lactate dehydrogenase-elevating virus
(LDV) of mice, and simian hemorrhagic fever virus (SHFV).
The arteriviruses are now re-grouped into the newly created
order Nidovirales, together with the Coronaviridae family
(Cavanagh, 1997). The PRRSV genome consists of the 5V
untranslated region (UTR), nine open reading frames (ORF1a,
ORF1b, ORF2a, ORF2b, and ORFs 3 through 7), and the 3V
UTR followed by a polyadenylation tail (Meulenberg et al.,
1993; Snijder and Meulenberg, 1998; Wootton et al., 2000).
ORF1a and ORF1b are translated into the 1a and 1ab
polyproteins, respectively, which are then proteolytically
processed into 13 non-structural proteins believed to be
involved in genome replication and transcription (van Dinten
et al., 1999; Wootton et al., 2000; Bautista et al., 2002). ORFs
2a through 7 encode six membrane-associated proteins (GP2a,
2b or E, GP3, GP4, GP5, and M) and a nucleocapsid (N)
protein, and these proteins are translated from a nested set of
3V-coterminal subgenomic mRNAs (Meulenberg et al., 1995;
Snijder and Meulenberg, 1998; Wu et al., 2001).
The N protein of PRRSV is a small basic protein with an
isoelectric point of 10.4 and is comprised of 123 or 128 aminoFig. 1. (A) The Fpat7_ nuclear localization signal (NLS, darkened area) of the wild-
positions. WT, wild-type N protein; KK/43.44/GG, lysine substitutions to glycine in
N gene. PCR-based site-directed mutagenesis was performed using the wild-type N
glycine. The N gene was sequenced from the NLS-null N gene. Amino acids are pre
FKKS_ to FGGN_. (C) Subcellular localization of N proteins in Cos-7 cells (upper
panel) or pCi-Neo-N-KK/43.44/GG (right panel). Gene-transfected cells were incuba
with Alexa green conjugated goat anti-mouse antibody. Nucleus (Nu) and nucleolus (
protein (KK/43.44/GG) shows the absence of N protein in the nuclei and nucleoli.acids for the North American and European genotypes,
respectively (Snijder and Meulenberg, 1998; Wootton et al.,
2002). The N protein is the most abundant viral protein in
infected cells and constitutes about 40% of the protein content
in the virion (Snijder and Meulenberg, 1998). It is highly
immunogenic in pigs and believed to be multifunctional
(Rodriguez et al., 1997; Wootton et al., 1998). The N protein
is a serine-phosphoprotein with unknown functions (Wootton
et al., 2002). As the sole structural protein component of the
viral capsid, the PRRSV N protein associates with itself by
both covalent and non-covalent interactions, providing the
basis for viral capsid assembly. The covalently linked N–N
homodimerization is formed in the lumen of the endoplasmic
reticulum (ER) and the Golgi complex through disulfide
linkages via a cysteine residue at position 23 (Wootton and
Yoo, 2003). Cysteine 23 of the N protein has recently been
shown to be essential for virus replication and infectivity,
indicating an essential role of the disulfide-linked N–N
homodimerization during virion assembly (Lee et al., 2005).
The entire life cycle of PRRSV occurs in the cytoplasm of
infected cells, and accordingly, the PRRSV N protein is
predominantly found in the cytoplasm and the perinuclear
region. Interestingly, the PRRSV N protein is also found in the
nucleus and nucleolus of infected cells (Rowland et al., 1999).
Nuclear localization of N proteins has been reported for EAV,
which is another arterivirus (Tijms et al., 2002), and for several
coronaviruses including avian infectious bronchitis virus,
transmissible gastroenteritis virus of swine, and murine
hepatitis virus (Hiscox et al., 2001; Wurm et al., 2001). A
functional nuclear localization signal (NLS) for the PRRSV N
protein has been identified in the stretch of basic amino acids
(PGKKNKK) at positions 41 to 47 and has been shown totype N protein and the NLS-null mutant protein. Numbers indicate amino acid
the N protein. (B) Electrophoregram of the wild-type N gene and the NLS-null
gene pCi-Neo-N to change codons for lysine at positions 43 and 44 of N to
sented in a single letter code. Bold letters indicate substituted amino acids from
panel) and Marc-145 cells (lower panel) transfected with pCi-Neo-N-WT (left
ted for 2 days and reacted with N-specific MAb SDOW17 followed by staining
No) are indicated by arrows. Intracellular localization of the NLS-null mutant N
magnification 40.
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(Rowland et al., 2003). Therefore, it is believed that the N
protein localizes in the nucleus through the NLS-dependent
importin a/h-mediated nuclear transport pathway. It is note-
worthy that the N protein nuclear localization does not require
N–N disulfide-linked dimerization (Lee et al., 2005). Once in
the nucleus, the N protein colocalizes and specifically interacts
with the small nucleolar RNA-associated protein fibrillarin,
implicating an involvement of N in the ribosome biogenesis.
Indeed, the N protein has been shown to be able to bind both
28S and 18S ribosomal RNA as well as the viral genomic RNA
(Yoo et al., 2003). Since PRRSV assembly and maturation take
place in the ER and the Golgi regions, it seems that the PRRSV
N protein plays both a structural role in the cytoplasm and a
non-structural role in the nucleus and/or nucleolus. The
biological relevance of the N protein nuclear localization and
its function during infection is presently unknown.
In the present study, a reverse genetics system for PRRSV
(Lee et al., 2005) was used to investigate the biological
significance of N protein nuclear localization during infection.Fig. 2. Infectivity of the P129-GG full-length genomic clone. CPE, cytopathic effects;
transfected with 2 Ag of P129-WT or P129-GG DNA and incubated for 3 days. CP
inverted microscope. For immunostaining, cells were reacted with SDOW17 at 2 da
conjugated with Alexa green. Nucleus (Nu) and nucleolus (No) are indicated by arrow
spots correspond to the wild-type N protein and the NLS-null mutant N protein. The w
NLS-null protein was excluded from the nucleus. Plaque morphology of P129-WT (K
agarose and further incubated for 5 days. Plaques were stained with 0.01% neutral re
comparison to wild-type plaques.An NLS-null mutant virus was generated using an infectious
cDNA clone and used to demonstrate that N protein nuclear
localization is non-essential for virus replication. Pigs infected
with the NLS-null mutant virus exhibited a significantly shorter
duration of viremia accompanied by significantly higher titers
of neutralizing antibodies than in wild-type virus-infected pigs.
The data show strong selection pressure for reversion of the
NLS-null at the NLS locus of the N protein.
Results
Substitution of lysine to glycine in NLS and N protein nuclear
localization
The North American genotype PRRSV N protein contains
two putative NLS motifs at positions 10 to 13 (10-KRKK) and
41 to 47 (41-PGKKN/SKK), and these motifs resemble Fpat4_
and Fpat7_ NLS, respectively. Previous work using the PRRSV
SDSU-23983 isolate showed that the Fpat7_ NLS was
necessary and sufficient for nuclear localization of N (RowlandSDOW-17, monoclonal antibody specific for the N protein. Marc-145 cells were
Es became visible at 3 days post-transfection and were photographed using an
ys post-transfection followed by incubation with the goat anti-mouse antibody
s. (D to F) Magnification 20; (G to I) magnification 40. The intensely stained
ild-type N protein was concentrated in the both cytoplasm and nucleus, while the
) and P129-GG (L). At 24 h of DNA transfection, cells were overlayed with 0.8%
d and photographed. Note that the size of plaques for P129-GG virus is small in
Fig. 3. Growth kinetics of the NLS-null P129-GG virus in Marc-145 cells. (A)
Titers of wild-type virus and NLS-null P129-GG virus during the first three
passages. The P129-WT and P129-GG viruses were passaged three times in
Marc-145 cells and titrated by plaque assay. The titers are expressed in log10
PFU/ml. The culture supernatants from DNA-transfected cells were designated
Fpassage-1_. Error bars represent standard errors of mean values from two
independent experiments. At each passage number mean titers with different
capital letters (A, B, or C) differ significantly ( P < 0.05). (B) One-step growth
curves for P129-WT and P129-GG virus. Cells were infected at an MOI of 1–5
with the passage-3 preparation of indicated virus in duplicate. Samples were
taken at the indicated times, and virus titers were determined by plaque assay.
The results are expressed as mean values from two independent experiments,
and error bars represent standard errors of mean values from two experiments.
At each day post-infection, mean titers with different capital letters (A, B, or C)
differ significantly ( P < 0.05).
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at 43 and 44 suggested that these two residues might constitute
a core sequence responsible for the N protein nuclear
localization. Lysines at 43 and 44 of 41-PGKKNKK were
substituted to glycine, and a Fpat7-modified_ mutant N gene
was constructed and designated KK/43.44/GG (Figs. 1A and
B). The KK/43.44/GG gene was transfected into COS-7 cells,
and at 48 h post-transfection, cells were stained with the N-
specific MAb SDOW-17. The wild-type N protein accumulated
both in the cytoplasm and the nucleus with a distinct nucleolar
staining (Fig. 1C), but expression of the KK/43.44/GG protein
was restricted to the cytoplasm and perinuclear regions with no
staining in the nucleus and nucleolus (Fig. 1C). Subcellular
distribution of KK/43.44/GG protein was also examined in
Marc-145 cells since this is the established cell line permissive
for PRRSV infection. As with COS-7 cells, Marc-145 cells also
showed cytoplasmic and perinuclear stainings but absence of
staining in the nucleus, indicating that the lysines at 43 and 44
were essential amino acids for the function of the NLS of the N
protein.
Generation of NLS-null P129-GG virus
A reverse genetics system was applied to generate NLS-null
mutant PRRSV. In this system (Lee et al., 2005), the full-length
genomic cDNA is under the control of the cytomegalovirus
immediate early promoter. Direct transfection of plasmid DNA
initiates a full cycle of virus replication and produces infectious
progeny virus. By site-directed mutagenesis, the motif of 41-
PGKKSKK in the N gene of the shuttle plasmid was altered to
41-PGGGNKK. Nucleotide sequencing of screened clones
verified the presence of the FGGN_ modification in the full-
length clone. The FGGN_ mutation in the full-length clone was
designated pCMV-S-P129-GG. No additional mutation was
found throughout the N gene other than the FGGN_ mutation.
Infectivity of P129-GG
Infectivity of the NLS-null pCMV-S-P129-GG genomic
DNA clone was determined first by transfection into Marc-145
cells followed by observation for cytopathic effect (CPE). The
wild-type and NLS-null mutant clones induced weak CPE by 3
days post-transfection, and thereafter, the CPE became
prominent (Figs. 2B, C). The specificity of CPE was confirmed
by immunofluorescence staining using the N-specific MAb
SDOW17. Clusters of cells showed bright fluorescence,
indicating virus infection and spread of infection to neighbor-
ing cells (Figs. 2E, F). In cells transfected with the wild-type
clone, the N protein was distributed throughout the cytoplasm
and nucleoplasm, showing the nuclear translocation of N of the
molecularly cloned virus (Fig. 2H). By contrast, the N protein
staining in cells transfected with the NLS-null clone was
observed in the cytoplasm and the perinuclear region, but not in
the nucleus or nucleolus (Fig. 2I).
To prepare the stock of NLS-null virus, culture supernatants
were harvested at 5 days post-transfection (designated FP129-
GG_). Virus titers were determined to be 1 102, 4.0 102, and5 103 PFU/ml for passages one (P1), two (P2), and three (P3),
respectively (Fig. 3A). The wild-type (designated P129-WT)
virus was generated in parallel from the pCMV-S-P129 clone
with virus titers of 1  103, 7.9  103, and 6.3  105 PFU/ml,
for P1, P2, and P3, respectively (Fig. 3A). Thus, by P3, the
NLS-null mutant P129-GG virus had a titer 100-fold lower than
that observed for P129-WT. Viral plaques formed by P129-GG
were drastically reduced in size, and most plaques were of
pinpoint size (Fig. 2L), suggesting a negative effect of the NLS
mutation on the rate of cell-to-cell spread during infection.
To confirm whether the NLS mutation was still retained in
the P129-GG virus during passages in Marc-145 cells, RT-PCR
and sequencing were performed for the N gene using the P3
C. Lee et al. / Virology 346 (2006) 238–250242virus. To avoid possible carry-over DNA contamination from
transfections during P1 virus production, RNA preparations
were treated with RNase-free DNase I. Four hundred-base pair
PCR fragments were obtained from both P129-WT and P129-
GG, and sequencing results showed stable incorporation of the
FGGN_ mutation in the viral genome for at least three passages
in cell culture.
The one-step growth kinetics of P129-GG was determined
using P3 virus. Cells were infected with P3 virus at an MOI of
1 to 5 (Fig. 3B). The wild-type virus reached a titer of 1  105
PFU/ml by 3 days post-infection, and the titer increased to a
maximum of 6.3  105 PFU/ml by 5 days post-infection (Fig.
3B). In contrast, P129-GG showed retarded growth with titers
of 7.9  102 to 3.2  103 PFU/ml during 5 days of infection
(Fig. 3B). These data demonstrate that nuclear localization of
the PRRSV N protein is non-essential for virus multiplication,
but the FGGN_ mutation at the NLS locus reduces the growth
rate of PRRSV.
Experimental infection of pigs with NLS-null P129 GG virus
To examine in vivo effects of the NLS-null virus in the
natural host, a pig infection study was conducted. Following
challenge, pigs in the P129-GG and P129-WT groups
developed signs of a mild PRRS virus infection, but the
severity of clinical signs was similar in the two infected groups.
Fever, defined as a rectal temperature higher than 40 -C,
developed in four and six pigs in the P129-GG and P129-WTTable 1
Viremia in individual pigs inoculated with placebo, wild-type virus P129-WT, or N
Pig ID Inoculum Viremia (log10 PFU/ml) at day post-inoculat
0 4 7
27 Placebo –a – –
29 – – –
31 – – –
32 – – –
39 – – –
41 – – –
42 – – –
Meanc – –A –A
26 P129-WT – 1 1.3
28 – 1.3 1
30 – 1 2
35 – 1 1.5
37 – 0.7 1
40 – 2.8 3
43 – 1.5 1.7
Mean 0 1.3 B 1.7 B
33 P129-GG – 0.7 –
34 – 1.3 2.2
36 – 1.4 –
38 – 0.7 –
44 – 1.3 1.6
45 – 1.3 2.7
46 – 1.3 –
Mean 0 1.1B 0.9AB
a – , no viremia.
b NA, not applicable due to early euthanasia.
c In each column, means with different superscripts (A, B, or, C) differ significantgroups, respectively. Between 3 and 6 days post-infection, pigs
infected with P129-WT tended to have slightly higher
temperatures than P129-GG pigs (data not shown). Weight
gains were numerically higher in pigs infected with P129-GG
virus than in pigs infected with P129-WT but did not differ
significantly (data not shown).
While animals in the control group remained PRRSV
negative throughout the study, pigs inoculated with either
P129-WT or P129-GG developed viremia by 4 days post-
infection (Table 1). In pigs inoculated with P129-WT, mean
duration of viremia was significantly longer than in P129-GG
inoculated pigs (8.7 days and 5.7 days, respectively). The peak
mean virus titer in serum was higher for P129-WT inoculated
pigs than for pigs receiving P129-GG (5  101 PFU/ml and
1.3  101 PFU/ml, respectively), but the difference was not
statistically significant. These data suggest that an NLS-null
mutant virus induces a lower viral load and shorter duration of
viremia compared to those in wild-type virus-infected pigs.
All pigs infected with P129-GG or P129-WT seroconverted
by 10 days post-infection, as evaluated by ELISA (IDEXX
Laboratories, Westbrook, Maine) (Fig. 4). Placebo pigs
remained seronegative. The mean S/P ratio of antibody for
P129-GG pigs was higher than that of P129-WT pigs (2.3 and
1.8, respectively), but the difference was not statistically
significant.
In pigs infected with P129-WT, serum neutralizing (SN)
antibodies were detected by 14 days post-infection and reached
a geometric mean titer (GMT) of 4.3 by 28 days post-infection.LS-null mutant virus P129-GG
ion Duration of
viremia in days
10 14 21 28
– – – – 0
– – – – 0
– – NAb NA 0
– – NA NA 0
– – – – 0
– – – – 0
– – – – 0
–A – – – 0A
1 – NA NA 10
– – – – 7
1 – – – 10
– – – – 7
– – NA NA 7
1 – – – 10
1 – – – 10
0.6 B 0 0 0 8.7 B
– – – – 4
– – NA NA 7
– – – – 4
– – – – 4
– – NA NA 7
1.9 – – – 10
– – – – 4
0.3AB 0 0 0 5.7C
ly ( P < 0.05).
Fig. 5. Virus-neutralizing antibodies in the sera of pigs inoculated with wild-
type virus or NLS-null mutant P129-GG virus. Neutralizing antibody titers are
expressed on a log2 scale. Error bars represent standard errors for each group of
pigs at the indicated time. At each time point, means with different capital
letters (A, B, or C) differ significantly ( P < 0.05).
Fig. 4. Serum antibody response for PRRSV in pigs infected with wild-type
virus or NLS-null mutant P129-GG virus. PRRSV-specific serum anti-
bodies were determined using the HerdCheckR PRRS ELISA 2XR kit. S/P
ratios of greater than 0.400 are considered positive. Error bars represent
standard errors of the mean. At each time point, means with different
capital letters (A, B, or C) differ significantly (Kruskal–Wallis non-
parametric test, P < 0.05).
C. Lee et al. / Virology 346 (2006) 238–250 243In contrast, neutralizing antibody responses developed faster
and higher in pigs infected with P129-GG. SN titers in this
group reached a GMT of 9 by 21 days post-infection and
increased to a GMT of 18 by 28 days post-infection (Fig. 5).
These data suggest that pigs infected with P129-GG virus
generate significantly higher neutralizing antibody titers than
pigs infected with wild-type virus.
At 14 days post-infection, gross lung lesions were
determined in two pigs from each group, and limited areas
of atelectasis of lung tissue and varying degrees of
lymphadenopathy were noted. Lung lesions did not appear
significantly different between pigs from different virus
treatment groups. Overall, lung lesion scores in pigs were
similar and minimal, regardless of the treatment group (data
not shown).
Reversions of NLS-null virus in pig 45
In comparison to values for other pigs within the same
P129-GG group, pig 45 showed a higher viral load during
viremia (5.0  102 PFU/ml vs. maximum mean titer of
1.3  101 PFU/ml), lower ELISA S/P ratios (1.002 vs. a
mean of 2.757 in other P129-GG pigs at 28 days post-
infection), and lower SN titers (5.7 for pig 45 vs. a GMT SN
titer of 24.7 for the rest of the group at day 28). Similar
values were observed in pigs infected with wild-type virus,
suggesting reversion of the FGGN_ mutation at the NLS
locus. To examine this hypothesis, plaque assays were carried
out using Day 7 post-infection serum samples from pig 45.
Ten well-isolated individual plaques were picked and sub-
jected to direct extraction of RNA followed by RT-PCR for
the N gene and sequencing. Fig. 6A shows the nucleotide
and deduced amino acid sequences for the NLS region of N
from each plaque. The sequence data revealed that nineplaques out of 10 were mutated; six plaques mutated to 41-
PGRRNKK, 41-PGRGNKK, or 41-PGGRNKK, and three
plaques mutated to 43-PGKKSKK (Fig. 6A). Only one
plaque out of 10 retained the original NLS-null sequence of
41-PGGGNKK. No other mutation was found elsewhere in
the N gene in the ten plaques from pig 45. The mutated
amino acids represented an arginine mutation at position 43
or/and 44. Since arginine may substitute for lysine without
disruption of the NLS function (Horton and Nakai, 1997),
the mutated plaques likely reflect functional NLS reversions
(Fig. 7). Reversions could not be found in other pigs in the
same group. Similarly, no mutation was found in the N gene
of the virus isolated from pigs infected with wild-type virus.
The original NLS-null mutant virus was cultivated in Marc-
145 cells for 20 passages, and the N gene was sequenced
from the passage 20 virus. No additional mutation was found
in the N gene. These data suggest strong selection pressure at
the NLS locus of N for reversion during replication of
PRRSV in pigs.
Virus persistence in tonsils
One of the hallmarks of PRRSV infection is viral
persistence in pig tonsils for a prolonged period of time.
Numerous reports show that infectious virus may persist for
up to 150 days following infection (Allende et al., 2000;
Wills et al., 1997). In the present study, tonsils from all pigs
infected with P129-GG or P129-WT were positive for the N
gene by RT-PCR (Fig. 6B), indicating that all infected pigs
harbored the virus in the tonsils for at least 4 weeks post-
infection. No mutation was found in the N gene from the
P129-WT pigs, and their sequences retained the wild-type
NLS motif of 43-PGKKNKK. Pigs infected with P129-GG,
however, all showed mutation of at least one nucleotide at the
Fig. 6. The nucleotide (left) and deduced amino acid (right) sequences at the NLS motif from viral plaques obtained from pig45 infected with P129-GG virus (A).
Plaque assays were carried out in Marc-145 cells using serum samples collected at 7 days post-infection from pig45. Ten plaques were randomly chosen, and total
RNA was extracted from each plaque. The N gene was PCR-amplified and sequenced. (B) Persistence of PRRSV in the tonsils of infected pigs. The tonsils were
taken from pigs at 28 days post-infection, and total RNAwas extracted from the tonsil homogenates. The N gene was amplified by RT-PCR and visualized on a 1%
agarose gel. 400-bp fragments are visible in the tonsils from infected pigs. Nucleotide and deduced amino acid sequences at the NLS locus of N gene products were
determined and presented. Boldfaces indicate changed nucleotides and the corresponding amino acids. P129-WT denotes wild-type virus; P129-GG denotes the
NLS-null mutant.
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to arginine at either position 43 or 44 (Fig. 6B). It is
noteworthy that such a mutation to 43-PGRGNKK or 43-
PGGRNKK represents a potentially functional Fpat7_ NLS
motif, implicating possible association of PRRSV persistence
with the nuclear localization of N in the tonsils of these
pigs.Fig. 7. Nuclear localization of N proteins from the NLS reversions arising during vire
NLS of 41-PGKKNKK, was mutated by site-directed mutagenesis to 41-PGGGNK
gene construct was transfected to Marc-145 cells for 2 days, and the cells were im
nuclear localization. Nucleus (Nu) and nucleolus (No) are indicated by arrows.N protein nuclear localization of revertants
Since mutations at the NLS locus were found from various
plaques isolated in pig 45 (Fig. 6A) as well as from the tonsils
of pigs infected with P129-GG (Fig. 6B), it was of particular
interest to assess nuclear localization of reverted N proteins. A
total of four different mutation patterns were identified duringmia and persistence. The wild-type N gene in pCi-Neo, containing the wild-type
K, 41-PGKKSKK, 41-PGRGNKK, 41-PGGRNKK, or 41-PGRRNKK. Each N
munostained using the N-specific MAb SDOW17 to determine the N protein
C. Lee et al. / Virology 346 (2006) 238–250 245viremia and persistence from NLS-null virus-infected pigs:
41-PGRGNKK, 41-PGGRNKK, 41-PGRRNKK, and 41-
PGKKSKK. These mutations were subsequently introduced
to the wild-type N gene by site-directed mutagenesis. Four
different reversion types of N were individually transfected
into Marc-145 cells for 2 days, and the cells were stained with
N-specific MAb SDOW17. All four types of reversions were
able to translocate the N proteins to the nucleus and nucleolus
(Fig. 7), demonstrating that all reversions regained a functional
NLS. The function of 41-PGRGNKK was somewhat unex-
pected, as it does not conform to the previously defined ‘‘pat7’’
NLS motif (Rowland et al., 1999, 2003).
Discussion
The primary replication site for most RNA viruses is the
cytoplasm of infected cells. During the past decade, however,
some RNA virus proteins have been shown to localize to the
nucleus and nucleolus (reviewed in Hiscox, 2003). It is
postulated that these viruses have evolved to utilize nuclear
functions of the cell to favor productive infections, to inhibit
the synthesis of competing cellular macromolecules, or to
modulate antigen presentation or innate immunity. A number
of RNA virus proteins that are translocated to the nucleus and
nucleolus have effects on the host cell nuclear functions
through inhibition of host cell transcription, disruption of
nucleocytoplasmic transport pathways, and induction of
nuclear herniations in order to facilitate their replication and
to inhibit host antiviral responses (Aminev et al., 2003a, 2003b,
2004; Chen et al., 2002; Hoyt et al., 2004; Petersen et al., 2000;
Sharma et al., 2004). It has been difficult, however, to study
such functions in vivo using replicating virus because of the
need for reverse genetics systems to generate appropriate
mutants. In one study using a mutant Semliki Forest virus (a
member of the alphaviruses), in mice, a single amino acid
change in the NLS locus of the nsP2 protein disrupted nsP2
nuclear transport and modified the neurovirulence of the virus
(Fazakerley et al., 2002; Rikkonen, 1996).
As with many other RNA viruses, PRRSV replicates in the
cytoplasm, and the PRRSV proteins are largely distributed in
the cytoplasm. The viral N protein, however, has been shown
to localize both in the cytoplasmic and nucleolar compartments
in porcine alveolar macrophages and Marc-145 cells (Rowland
et al., 1999). The functional NLS has been identified in the N
protein, and its nuclear interaction with fibrillarin has been
characterized (Rowland et al., 2003; Yoo et al., 2003). In the
present study, we investigated the biological importance of N
protein nuclear localization during infection in cultured cells
and in pigs. It was once speculated that the induction of CPE
by PRRSV infection could be related to the nuclear localization
of N protein (Rowland and Yoo, 2003). However, Marc-145
cells infected with the NLS-null mutant virus produced
cytopathology indistinguishable from that of wild-type virus,
but with lower viral titers and smaller size plaques. Our data
demonstrate that nuclear localization of N is not related to
PRRSV cytopathology and is not essential for production of
infectious progeny.Acute infection by PRRS virus causes viremia that is
detectable commonly at 2 to 11 days post-infection, but up to
23 days in some pigs (Allende et al., 2000). In this experiment,
the onset of viremia was detected as early as 4 days post-
infection in infected pigs, but none of the pigs continued to
harbor the virus in their sera by 14 days. The sensitivity of
virus isolation from serum specimens may be limited to 2
weeks post-infection. Other methods of virus detection with
greater sensitivity such as real-time RT-PCR may have been
able to detect virus after 14 days but would not distinguish
infectious virus from residual viral RNA. The shorter duration
of viremia in P129-GG pigs probably reflects growth attenu-
ation of the NLS-null virus.
PRRSV-infected pigs produce detectable IgG at 7 to 14 days
post-infection with an increase to 4 weeks post-infection
followed by decline and persistence for 1 year (Labarque et
al., 2000; Rossow et al., 1994; Yoon et al., 1995). In our study,
seroconversion was detectable by 10 days post-infection in all
virus-infected pigs, but virus neutralizing antibody titers were
significantly higher in P129-GG infected pigs by 3 weeks post-
infection. A typical immune response to PRRSV in pigs is
characterized by early production of non-neutralizing antibo-
dies followed by the delayed appearance of neutralizing
antibodies between 2 and 4 weeks post-infection, which then
persist at low levels. Moreover, typical titers of serum
neutralizing antibodies are between 2 and 12, titers which are
considered unusually low in comparison with those induced by
viruses of other families (Labarque et al., 2000; Loemba et al.,
1996). The role of antibodies in protection is also uncertain
since PRRSV can replicate and spread in pigs even in the
presence of circulating antibodies (Loemba et al., 1996;
Rossow et al., 1995). In contrast, the protective effects of
passively transferred PRRSV-specific neutralizing antibodies
have been demonstrated, suggesting that serum neutralizing
antibodies may be the key component for protection from
PRRSV infection (Lopez and Osorio, 2004; Osorio et al.,
2002). PRRSV-specific antibody-dependent enhancement of
infection has also been reported (Yoon et al., 1996). In the
present study, pigs infected with P129-GG had detectable SN
titers by 3 weeks post-infection; titers increased to 18 by 4
weeks. It is of interest to examine whether the increased SN
titers in P129-GG infected pigs contribute to better protection
against PRRSV infection. In the present study, the appearance
of SN antibodies coincided with disappearance of viremia after
14 days of infection. Immune responses in the P129-GG
infected pigs may have led to lower viral replication and faster
clearance of virus from the serum.
Pig 45 exhibited responses distinct from those of other
animals in the P129-GG group. Direct sequencing of viral
plaques demonstrated that mutation of the P129-GG virus had
indeed occurred in this pig. Mutant viruses contained at least
one amino acid change within the NLS locus at positions 43
through 45 of N. Mutated N proteins were able to translocate to
the nucleus and nucleolus, suggesting alterations of both
genotype and phenotype of the null mutant during infection.
Although these changes were extremely minor at the genomic
sequence level (1 or 2 nucleotide changes out of the total
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sequences during infection of the pig. Considering that the N
gene is the most stable gene in PRRSV in pigs (Le Gall et al.,
1998), the appearance of such reversions during the relatively
short period of infection is surprising. The data suggest the
presence of strong selection pressure at the NLS locus of N for
functional NLS in the host.
PRRSV infection generally leads to virus persistence
characterized by limited virus replication in the lymphoid
tissues. Shedding of virus from persistently infected animals is
a main factor which makes the control of PRRS difficult in the
field (Allende et al., 2000; Wills et al., 1997). The mechanism
of PRRS virus persistence is unknown. During persistence,
structural genes are generally variable, with the exception of
the N gene which is considered genetically stable (Allende et
al., 2000). The genetic stability of the N gene has also been
observed for EAV during persistence in stallions (Hedges et al.,
1999). It is interesting to note that the EAV N protein also
specifically localizes to the nucleus upon infection (Tijms et al.,
2002). In the present study, both wild-type and P129-GG
viruses persisted at least for 1 month in the tonsils of pigs.
Surprisingly, all P129-GG viruses isolated from the tonsils of
infected pigs harbored mutations at the NLS locus. In all cases,
one or two nucleotide changes occurred, and these changes led
to amino acid alterations from glycine to arginine at position 43
or 44 of N. The preferential mutation to arginine is explained
by the fact that a single nucleotide change from FG_ to FA_will
code for arginine, whereas two nucleotide changes are required
to code for lysine. No silent mutations were found in more than
18 plaques examined. The arginine mutation at position 43 or
44 reverted the NLS-null virus to a functional phenotype.
Indeed, the N proteins containing an arginine mutation at 43 or
44 were all found to localize in the nucleus and nucleolus. The
observation that 41-PGRGNKK was positive for NLS function
was unexpected, since it deviates from the ‘‘pat7’’ motif
definition of a proline followed within three residues by a
segment containing three basic residues (K or R) out of four
(Rowland et al., 1999, 2003). In order to accommodate all
functional sequences, the NLS motif of North American
genotype PRRSV N proteins is herein expanded and redefined
as a ‘‘pat8’’ motif: a proline followed within three residues by a
segment containing at least three basic residues (K or R) out of
five. The corresponding sequences in isolates VR-2332 and
P129 are 41-PGKKNKKK and 41-PGKKSKKK, respectively.
The most common functional NLS revertant found in tonsils
during the present study, 41-PGRGNKKK, conforms to the
pat8 (but not the pat7) pattern. A review of sequences in
Genbank reveals that nearly all North American PRRSV
isolates conform to the pat7 motif, but there are three ex-
ceptions. Genbank accession numbers AF043951, AY209228,
AY262352 describe field isolates with NLS sequences of 41-
PGKNNKKK, 41-PGKKNMKR, and 41-PGKKNNKR, re-
spectively. The pat8 motif encompasses these and all other
known North American PRRSV N protein sequences (over 70
at the time of this analysis). Collectively, our data suggest a
potential correlation of the N protein nuclear localization and
viral persistence or virus fitness. N protein nuclear localizationmay play an important role in evasion of host immune
mechanisms by PRRSV.
Materials and methods
Cells, viruses, and antibodies
Marc-145 cells (a subclone of MA104 cells; Kim et al.,
1993) and COS-7 cells were grown in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 8% fetal bovine
serum (FBS; Gibco BRL), penicillin (100 U/ml), and strepto-
mycin (50 Ag/ml). Cells were maintained at 37 -C with 5%
CO2. Stocks of reconstituted viruses derived from infectious
cDNA clones were prepared after three passages in Marc-145
cells. Titers of the viruses were determined by standard plaque
assays. Plaque assays were carried out in duplicate in Marc-145
cells using 6-well plates of 35 mm in diameter per well. Virus-
infected cell monolayers were overlayed with 0.8% agarose in
DMEM and incubated at 37 -C. At 5 days post-infection,
plaques were stained with 0.01% neutral red, and plaque
numbers were determined. Monoclonal antibodies (MAbs)
specific for N are described elsewhere (Nelson et al., 1993;
Wootton et al., 1998). E. coli strains XL1-Blue (Stratagene)
and DH5a were used as hosts for site-directed mutagenesis and
general cloning, respectively.
Generation of NLS-deficient full-length PRRSV cDNA clones
To modify the NLS (41-PGKKSKK for P129 strain; 41-
PGKKNKK for PA8 strain) at positions 41 to 47 of the N protein,
PCR-based site-directedmutagenesiswasconducted to substitute
codons for lysine residues at positions 43 and 44 (genomic
nucleotidepositions14,999 to15,004) tocodons forglycineusing
pCi-Neo-N and the shuttle plasmid with the following primer
pairs: for KK43/44GG mutation, KK43/44GG-Fwd (5V-
GGCAAGGGACCGGGAGGGGGAAATAAGAAGAAA-
AAC-3V: nucleotide positions 14,984 to 15,019) and KK43/
44GG-Rev (5V-GTTTTTCTTCTTATTTCCCCCTCCCGGT-
CCCTTGCC-3V: nucleotide positions 14,984 to 15,019), where
underlines indicate codon changes for amino acid substitutions
from FKKS_ to FGGN_. PCR-basedmutagenesis and screening of
mutants were performed as described previously (Wootton et al.,
2001). The cDNA cloning of the N gene from the PRRSV strain
PA-8 into pCi-Neo (Promega) to produce pCi-Neo-N is described
elsewhere (Wootton et al., 2002).
The shuttle plasmid pTB-shuttle-N-GG carrying the NLS
mutation was digested with BsrG I and Spe I, and a 2772-bp
fragment was purified. The wild-type full-length genomic
cDNA clone was digested with BsrG I and Spe I, and the 2772-
bp BsrG I-Spe I fragment was replaced with the corresponding
fragment obtained from the shuttle plasmid. The ligated full-
length plasmid DNA was screened by Xma I digestion, and
based on the Xma I digestion pattern, positive clones were
selected. DNA manipulation and cloning were performed
according to standard procedures (Sambrook and Russell,
2001). The selected clones were sequenced to confirm the
presence of FGGN_ modification in the full-length genomic
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P129-GG.
Immunofluorescence staining
Marc-145 cells or COS-7 cells were seeded on microscope
coverslips placed in 35-mm-diameter dishes and grown
overnight to 70% confluence. The cells were transfected with
2 Ag of plasmid DNA using Lipofectin according to the
manufacturer’s instruction (Invitrogen). At 48 h post-transfec-
tion, cell monolayers were washed twice in PBS and fixed
immediately with cold methanol for 10 min at 20 -C. Cells
were blocked using 1% bovine serum albumin in PBS for 30
min at room temperature and then incubated with N-specific
MAb SDOW17 for 2 h. After washing five times in PBS, the
cells were incubated for 1 h at room temperature with goat anti-
mouse secondary antibody conjugated with Alexa green dye
(Molecular Probes). The coverslips were washed five times in
PBS and mounted on microscope glass slides in mounting
buffer (60% glycerol and 0.1% sodium azide in PBS). Cell
staining was visualized using a fluorescent microscope (model
AX70, Olympus).
Production of virus from full-length cDNA clones
Marc-145 cells were seeded in 35-mm-diameter dishes and
grown to 70% confluency. Cells were transfected for 24 h with
2 Ag of the full-length cDNA plasmid using Lipofectin.
Transfected cells were incubated for 5 days at 37 -C in
DMEM supplemented with 8% FBS. The culture supernatants
were harvested at 5 days post-transfection and designated
Fpassage-1_. The passage-1 virus was used to inoculate fresh
Marc-145 cells, and the 5-day harvest was designated Fpassage-
2_. The Fpassage-3_ virus was prepared in the same way as for
passage-2. Each passage virus was aliquoted and stored at 80
-C until use.
RT-PCR and sequencing of N gene
Viral RNAwas extracted from either supernatants or lysates
of infected cells using the QiaAmp viral RNA mini-kit
(Qiagen). To remove any possible contamination of DNA in
the RNA preparations, samples were treated with 1 unit of RQ
DNase I (Promega) per microgram at 37 -C for 30 min in 50
mM Tris–HCl [pH 7.5] and 1 mM MgCl2. First-strand cDNA
synthesis was performed by Moloney Murine Leukemia Virus
(M-MLV) reverse transcriptase (Invitrogen) using the reverse
primer ORF7-Rev (5V-AGAATGCCAGCCCATCA-3V). The N
gene was amplified by Taq DNA polymerase (Invitrogen)
using ORF7-Fwd (5V-CCTTGTCAAATATGCCAA-3V) and
ORF7-Rev under the following conditions: initial denaturation
at 95 -C for 5 min, 35 cycles of: denaturation at 95 -C for 30 s,
annealing at 56 -C for 30 s, and extension at 72 -C for 1 min,
followed by a final extension at 72 -C for 7 min. PCR products
were analyzed by 1% agarose gel electrophoresis. Amplified
products were purified using the PCR purification kit (Qiagen)
and sequenced.Preparation of virus inocula
Due to the low titer of P129-GG virus, the Fpassage-3_ virus
was concentrated for pig experiments. Cells were plated in 50
dishes of 100-mm-diameter and grown overnight to 70%
confluency. The cells were infected with the Fpassage-2_ P129-
GG virus at a multiplicity of infection (MOI) of 0.1 for 1 h at
37 -C. Following infection, 5 ml of fresh medium containing
8% FBS was added, and incubation continued for 4 days.
When extensive CPE had developed, culture supernatants were
harvested and pooled, and cell debris was removed by a low-
speed centrifugation for 10 min at 1350  g. The supernatant
was then pelleted by a high-speed centrifugation for 90 min in
a JA-14 rotor (Beckman) at 30,000  g and 4 -C. The pellet
was resuspended overnight in one tenth of the original volume
at 4 -C. Recovery of infectivity of the concentrated virus was
determined by plaque assay on Marc-145 cells, and the virus
stock was stored at 80 -C until use.
Experimental infection of pigs
Twenty-one York–Landrace piglets were obtained from a
PRRSV-free swine herd at 5 weeks of age. Piglets were pre-
screened serologically for evidence of exposure to PRRSV and
Mycoplasma hyopneumoniae and were acclimatized for 7
days in an isolation facility prior to infection. Animals were
randomly allotted to three groups, seven piglets per group, and
animals within the same group were housed in the same room.
Throughout the study, pigs were fed an age-appropriate non-
medicated diet and provided with water ad libitum. On the
day of challenge, the PRRSV stocks were diluted to make
2.5  104 PFU/ml, and each animal was infected with a total
of 5  104 PFU by instillation of 1 ml in each nostril. After
infection, an aliquot of each inoculum was back-titrated by
plaque assay to confirm the dose of infection. Clinical signs
for general condition, depression, loss of appetite, coughing,
sneezing, and respiratory distress were monitored and rectal
temperatures were measured daily in all pigs for the first
week. All pigs were weighed upon arrival at the site and at
necropsy. Blood samples were taken on days 0, 4, 7, 10, 14,
21, and 28 post-infection for virus isolation and serology.
Serum samples were aliquoted and stored immediately at
80 -C until use. Two pigs from each treatment group were
euthanized at 14 days post-infection to assess lung lesions,
and the remaining pigs were euthanized at 28 days post-
infection. At necropsy, the percent consolidation of each lung
lobe was estimated to calculate total lung lesion severity, and
a lung sample from a representative lesion was taken and
immersed in formalin for histopathological examination. At
Day 28 post-infection necropsy, tonsil samples were collected
from remaining pigs for evaluation of viral RNA via RT-PCR.
The infection study and necropsies were performed in the
animal isolation facilities of the Ontario Ministry of Agricul-
ture and Food, located at the Ontario Veterinary College,
University of Guelph (Guelph, Ontario, Canada). The study
protocol was approved by the University of Guelph Animal
Care Committee.
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Viremia was measured by plaque assay in Marc-145 cells in
duplicate. Cells were infected with 0.1 ml of 10-fold serial
dilutions of sera collected at indicated days. The number of
plaques was counted for each dilution, and virus titers were
expressed as PFU per milliliter. Antibody titers were deter-
mined at the Animal Health Laboratory of the Laboratory
Services Division, University of Guelph, using the commer-
cially available PRRSV antibody detection kit (HerdCheck
PRRS; IDEXX, Westbrook, Maine), accordingly to the
manufacturer’s instruction. ELISA results were expressed as
a ratio of the optical density for the sample compared to the
optical density for the positive control (S/P ratio). According to
the assay, an S/P ratio greater than 0.4 is considered positive for
the presence of PRRSV antibodies.
Serum neutralization tests were performed in Marc-145 cells
in a 96-well microtiter plate format using the wild-type PRRSV
P129-WT virus. The Fpassage-3_ P129-WT virus stock was
diluted in DMEM to make 200 PFU in a 50 Al volume. The
diluted virus was mixed with 50 Al of 2-fold dilutions of
individual sera obtained from 0, 1, 2, 3, and 4 weeks post-
infection. The mixtures were then incubated for 1 h at 37 -C,
and approximately 2  105 Marc-145 cells in 100 Al were
added to each well. After 5 days of incubation, individual wells
were scored by CPE. Serum neutralization tests were con-
ducted four times, each time in duplicate.
Isolation of revertants
To identify mutant virus arising during infection, plaque
assays were performed using serum samples taken at 7 days
post-infection. When plaques developed, individual plaques
were picked using pipettes, and the agarose plugs were
resuspended in 1 ml of DMEM. Total RNA was extracted
from the plaque suspension using TRIzol reagent (Invitrogen).
The plaque suspensions were also used to infect Marc-145
cells for virus isolation. To identify mutants during persis-
tence, tonsils taken at necropsy were homogenized in PBS,
and total RNA was extracted using TRIzol. RT-PCR was then
conducted to amplify the N gene followed by nucleotide
sequencing.
Testing NLS function of revertants
To examine whether N proteins of revertants were capable
of nuclear localization, mutations identical to the reverted
sequences were introduced into plasmid pCi-Neo-N-KK/43.44/
GG using the following primer pairs: for 41-PGRGNKK,
G43R-Fwd (5V-GGGACCGGGAAGGGGAAATAAG-3V: nu-
cleotide positions 14,989 to 15,010) and G43R-Rev (5V-CT-
TATTTCCCCTTCCCGGTCCC-3V: nucleotide positions
14,989 to 15,010); for 41-PGGRNKK, G44R-Fwd (5V-GGA-
CCGGGAGGGAGAAATAAGAAG-3V: nucleotide positions
14,990 to 15,013) and G44R-Rev (5V-CTTCTTATTTCTC-
CCTCCCGGTCC-3V: nucleotide positions 14,990 to 15,013);
and for 41-PGRRNKK, G43/44R-Fwd (5V-GGCAAGG-GACCGGGAAGGAGAAATAAGAAGAAAAAC-3V: nucleo-
tide positions 14,989 to 15,019) and G43/44R-Rev (5V-
GTTTTTCTTCTTATTTCTCCTTCCCGGTCCCTTGCC-3V:
nucleotide positions 14,989 to 15,019), where underlines
indicate codon changes for amino acid substitutions from GG
to RG, GR, or RR.
Statistical analysis
Statistical calculations were carried out using SAS version
9.1 (SAS Institute Inc., Cary, North Carolina). Comparisons of
virus titers and virus neutralization antibody titers were carried
out using logarithmically transformed data by analysis of
variance (ANOVA) with Duncan’s multiple comparison test
used when the ANOVA test indicated significant differences.
Comparisons of S/P ratios generated by the IDEXX PRRSV
ELISA were made using the Kruskal–Wallis non-parametric
test.
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